Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

UK 37248

Known as: UK-37,248, UK-37248 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
We have previously reported that inhibition of thromboxane synthesis results in an improvement in postischemic function in… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
1988
1988
We tested the hypothesis that the in vivo response of the canine peripheral lung to 1 ppm ozone is mediated, in part, by… Expand
1988
1988
The effect of five thromboxane-synthase inhibitors (UK-37248, UK-38485, UK-34787, CGS-13080 and OKY-1581) on arachidonic acid… Expand
Highly Cited
1987
Highly Cited
1987
We have reported previously that thromboxane A2/prostaglandin (PG)H2 and serotonin independently mediate the occurrence of cyclic… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
1987
1987
The actions of specific humoral mediators in the immediate response of the canine peripheral airways to antigen challenge are not… Expand
1983
1983
The effects of the thromboxane synthetase inhibitor dazoxiben on thrombus formation, platelet aggregation and vascular reactivity… Expand
Review
1983
Review
1983
1 UK-37248 (dazoxiben), an orally active thromboxane synthetase inhibitor, was evaluated in a double-blind trial of patients with… Expand
Highly Cited
1982
Highly Cited
1982
During incubation of citrated blood at 37 degrees C the levels of 6-keto prostaglandin F1 alpha (6-keto PGF1 alpha) and… Expand
Highly Cited
1981
Highly Cited
1981
Abstract UK-37,248, 4-[-2-(1H-imidazol-1-yl)ethoxy] benzoic acid hydrochloride, in a human platelet microsomal preparation of… Expand
1981
1981
Abstract UK-37,248, a potent thromboxane synthetase inhibitor, at a dose of 1 mg/kg dramatically protected against sudden death… Expand